Resistant hypertension (RH) is a severe form of hypertension associated with increased
cardiovascular risk. Although true RH affects less than 10% of the patients receiving …

Resistant hypertension is an important subtype of hypertension that leads to an increased
risk of cerebrovascular, cardiovascular, and kidney disease. The revised guidelines from the …

Arterial hypertension is the most prevalent risk factor associated with increased
cardiovascular morbidity and mortality. Although pharmacological treatment is generally well …

Resistant hypertension (RH) induces higher morbidity and mortality due to cardiovascular
disease and stroke than hypertension without treatment resistance. New guidelines define …

The prevalence of resistant arterial hypertension (RH) is approximately 10-12%. Ambulatory
Blood Pressure Monitoring is highly recommended in these patients to define true and white …

The publication of the first non-randomised proof-of-concept trial of renal denervation as a
treatment modality in treatment--resistant hypertension set the stage for a search for novel …

The long-term management of patients with resistant hypertension has been made even
more difficult by a “moving target” goal blood pressure (BP). The Seventh Report of the Joint …

Resistant hypertension, defined as blood pressure (BP) remaining above goal despite the
use of 3 or more antihypertensive medications at maximally tolerated doses (one ideally …

Resistant hypertension is common and known to be a risk factor for cardiovascular events,
including stroke, myocardial infarction, heart failure, and cardiovascular mortality, as well as …

Abstract Treatment-resistant hypertension (TRH) affects between 3 and 30% of hypertensive
patients, and its presence is associated with increased cardiovascular morbidity and …